McLean A J, Milligan G
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ.
Br J Pharmacol. 2000 Aug;130(8):1825-32. doi: 10.1038/sj.bjp.0703506.
Stable clones of HEK293 cells expressing either FLAG(TM) epitope-tagged, wild type human beta(1)- and beta(2)-adrenoceptors or C-terminally green fluorescent protein (GFP)-tagged forms of these receptors were established. The binding affinity of [(3)H]-dihydroalprenolol and other ligands was little affected by addition of GFP to the C-terminal of either receptor. Isoprenaline induced the internalisation of both beta(1)-adrenoceptor-GFP and beta(2)-adrenoceptor-GFP and following removal of the agonist both constructs were able to recycle to the cell surface. The extent of internalisation of beta(2)-adrenoceptor-GFP produced by isoprenaline was substantially greater than for beta(1)-adrenoceptor-GFP. C-terminal addition of GFP slowed markedly the rate of internalization of both the beta(1)-adrenoceptor and the beta(2)-adrenoceptor in response to isoprenaline. Sustained exposure to isoprenaline (24 h) produced substantially greater levels of downregulation of native beta(2)-adrenoceptor compared to beta(2)-adrenoceptor-GFP although both were equally effectively removed from the plasma membrane. Sustained exposure to isoprenaline resulted in a large fraction of beta(2)-adrenoceptor-GFP becoming trapped in internal vesicles/lysosomes but not degraded. Even after sustained exposure to isoprenaline a significant fraction of beta(1)-adrenoceptor-GFP remained at the cell surface. These results indicate that although GFP tagging of beta-adrenoceptors can provide qualitative visual patterns of agonist-induced receptor trafficking and regulation in HEK293 cells the quantitative details vary markedly from those obtained with the unmodified receptors.
建立了稳定表达带有FLAG(TM)表位标签的野生型人β(1)-和β(2)-肾上腺素能受体或这些受体C末端带有绿色荧光蛋白(GFP)标签形式的HEK293细胞克隆。[(3)H]-二氢阿普洛尔和其他配体的结合亲和力在任一受体的C末端添加GFP后几乎没有受到影响。异丙肾上腺素诱导β(1)-肾上腺素能受体-GFP和β(2)-肾上腺素能受体-GFP的内化,去除激动剂后,两种构建体都能够再循环到细胞表面。异丙肾上腺素诱导的β(2)-肾上腺素能受体-GFP的内化程度明显大于β(1)-肾上腺素能受体-GFP。C末端添加GFP显著减慢了β(1)-肾上腺素能受体和β(2)-肾上腺素能受体对异丙肾上腺素的内化速率。与β(2)-肾上腺素能受体-GFP相比,持续暴露于异丙肾上腺素(24小时)导致天然β(2)-肾上腺素能受体的下调水平显著更高,尽管两者从质膜上被同等有效地去除。持续暴露于异丙肾上腺素导致很大一部分β(2)-肾上腺素能受体-GFP被困在内质网泡/溶酶体中但未降解。即使在持续暴露于异丙肾上腺素后,仍有相当一部分β(1)-肾上腺素能受体-GFP留在细胞表面。这些结果表明,尽管β-肾上腺素能受体的GFP标记可以在HEK293细胞中提供激动剂诱导的受体转运和调节的定性视觉模式,但定量细节与未修饰受体获得的细节明显不同。